| 1 | 1319737 | Probucol increases the selective uptake of HDL cholesterol esters by Hep G2 human hepatoma cells. | Arterioscler Thromb | 1992 Jul |
1 |
| 2 | 1435295 | Probucol protects lipoprotein (a) against oxidative modification. | Metabolism | 1992 Nov |
2 |
| 3 | 1508964 | Probucol attenuates a reduction in serum immunoreactive insulin levels by interleukin in adrenalectomized rats. | Pharmacology | 1992 |
7 |
| 4 | 1632848 | Non-macrophage-related accumulation of cholesterol during probucol treatment in familial hypercholesterolemia: report of two cases. | Atherosclerosis | 1992 Feb |
2 |
| 5 | 1632859 | The effect of probucol on HDL-mediated sterol translocation and efflux from cells. | Atherosclerosis | 1992 May |
1 |
| 6 | 1639235 | Effect of hypolipidemic drugs on cholinesterase activity in the rat. | Gen Pharmacol | 1992 Mar |
1 |
| 7 | 1795436 | [Separation of high density lipoprotein (HDL) using anti-apo A-I, apo A-II immuno-affinity chromatography to evaluate the effects of probucol]. | Nihon Ronen Igakkai Zasshi | 1991 Nov |
3 |
| 8 | 1833606 | Probucol attenuated hyperglycemia in multiple low-dose streptozotocin-induced diabetic mice. | Life Sci | 1991 |
1 |
| 9 | 1856575 | Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment. | J Lab Clin Med | 1991 Aug |
1 |
| 10 | 1872919 | Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. | Atherosclerosis | 1991 Feb |
5 |
| 11 | 1903061 | Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. | Arterioscler Thromb | 1991 May-Jun |
1 |
| 12 | 1911715 | Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice. | Arterioscler Thromb | 1991 Sep-Oct |
2 |
| 13 | 1936105 | Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients. | Eur J Clin Invest | 1991 Aug |
4 |
| 14 | 2149270 | Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with alpha-tocopheryl nicotinate. | Atherosclerosis | 1990 Oct |
1 |
| 15 | 2248620 | Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4. | Atherosclerosis | 1990 Sep |
2 |
| 16 | 2295765 | Effects of long-term treatment with probucol on serum lipoproteins in cases of familial hypercholesterolemia in the elderly. | J Am Geriatr Soc | 1990 Jan |
1 |
| 17 | 2318380 | Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties. | FASEB J | 1990 Apr 1 |
4 |
| 18 | 2712860 | Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. | Atherosclerosis | 1989 Feb |
1 |
| 19 | 3260741 | Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. | Am J Cardiol | 1988 Jul 25 |
5 |
| 20 | 3355846 | Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine. | Biochim Biophys Acta | 1988 Apr 15 |
2 |
| 21 | 3394655 | Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbits. | Am J Cardiol | 1988 Jul 25 |
1 |
| 22 | 3394656 | Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer. | Am J Cardiol | 1988 Jul 25 |
1 |
| 23 | 3460320 | Medical management of hyperlipidemia and the role of probucol. | Am J Cardiol | 1986 Jun 27 |
1 |
| 24 | 3478721 | Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. | Proc Natl Acad Sci U S A | 1987 Nov |
1 |
| 25 | 3890872 | Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia. | Atherosclerosis | 1985 May |
1 |
| 26 | 6388586 | A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia. | Atherosclerosis | 1984 Oct |
1 |
| 27 | 6520542 | A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. | J Lipid Res | 1984 Nov |
2 |
| 28 | 6617725 | Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects. | Eur J Clin Pharmacol | 1983 |
1 |
| 29 | 6773532 | Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II. | Atherosclerosis | 1980 Jun |
1 |
| 30 | 6946776 | Effect of probucol on serum lipoprotein levels in normal and dyslipoproteinemic mice. | Atherosclerosis | 1981 Oct |
2 |
| 31 | 7161705 | Effects of some hypolipidemic drugs and phthalic acid esters on fatty acid binding protein in rat liver. | J Pharmacobiodyn | 1982 Oct |
1 |
| 32 | 7406949 | Probucol in hypercholesterolemia. A double blind study. | Atherosclerosis | 1980 Jun |
1 |
| 33 | 7417372 | Effect of probucol on cholesterol metabolism in the rat. | Atherosclerosis | 1980 Aug |
1 |
| 34 | 7503766 | The inhibitory effects of boldine, glaucine, and probucol on TPA-induced down regulation of gap junction function. Relationships to intracellular peroxides, protein kinase C translocation, and connexin 43 phosphorylation. | Biochem Pharmacol | 1995 Nov 9 |
7 |
| 35 | 7583537 | Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. | Arterioscler Thromb Vasc Biol | 1995 Oct |
1 |
| 36 | 7811748 | 3,5-Di-t-butyl-4-hydroxytoluene (BHT) and probucol stimulate selectively the reaction of mammalian 15-lipoxygenase with biomembranes. | Biochim Biophys Acta | 1995 Jan 3 |
1 |
| 37 | 7813167 | Clinical investigation on the hypolipidemic effect of simvastatin versus probucol in hemodialysis patients. | Clin Ter | 1994 Sep |
1 |
| 38 | 8051134 | Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. | J Biol Chem | 1994 Aug 12 |
1 |
| 39 | 8052654 | Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. | Proc Natl Acad Sci U S A | 1994 Aug 2 |
2 |
| 40 | 8205698 | Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. | Circulation | 1994 Jun |
1 |
| 41 | 8280187 | Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. | Atherosclerosis | 1993 Oct |
1 |
| 42 | 8312373 | The effects of LPS and probucol on interleukin 1 (IL-1) and platelet-derived growth factor (PDGF) gene expression in the human monocytic cell line U-937. | Biochim Biophys Acta | 1994 Feb 22 |
5 |
| 43 | 8461053 | Effects of the synthetic anti-oxidant, probucol, on the U937 monoblastoid cell line. | Atherosclerosis | 1993 Feb |
6 |
| 44 | 8485228 | [Probucol and alpha-tocopherol stimulate the synthesis of bile acids in cultured rabbit hepatocytes]. | Biokhimiia | 1993 Mar |
1 |
| 45 | 8485855 | Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia. | Clin Biochem | 1993 Apr |
1 |
| 46 | 8509722 | Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. | J Lipid Res | 1993 May |
3 |
| 47 | 8518741 | Peroxisome proliferators as inducers and substrates of UDP-glucuronosyltransferases. | Biol Cell | 1993 |
2 |
| 48 | 8645359 | Long-term probucol treatment results in regression of xanthomas, but in progression of coronary atherosclerosis in a heterozygous patient with familial hypercholesterolemia. | Atherosclerosis | 1996 Feb |
1 |
| 49 | 8696959 | Improvement of atherosclerosis and stiffness of the thoracic descending aorta with cholesterol-lowering therapies in familial hypercholesterolemia. | Arterioscler Thromb Vasc Biol | 1996 Aug |
1 |
| 50 | 8748220 | Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. | Nutrition | 1995 Sep-Oct |
2 |